1. Home
  2. TELA vs DARE Comparison

TELA vs DARE Comparison

Compare TELA & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TELA Bio Inc.

TELA

TELA Bio Inc.

HOLD

Current Price

$0.71

Market Cap

41.3M

Sector

Health Care

ML Signal

HOLD

Logo Dare Bioscience Inc.

DARE

Dare Bioscience Inc.

HOLD

Current Price

$2.09

Market Cap

33.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TELA
DARE
Founded
2012
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.3M
33.4M
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
TELA
DARE
Price
$0.71
$2.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$2.00
$10.00
AVG Volume (30 Days)
91.2K
176.3K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
37.59
N/A
EPS
N/A
N/A
Revenue
$80,275,000.00
$2,807,885.00
Revenue This Year
$10.23
$2,115.12
Revenue Next Year
$14.26
$122.62
P/E Ratio
N/A
N/A
Revenue Growth
15.84
N/A
52 Week Low
$0.50
$1.27
52 Week High
$2.19
$9.19

Technical Indicators

Market Signals
Indicator
TELA
DARE
Relative Strength Index (RSI) 41.10 46.47
Support Level $0.73 $1.94
Resistance Level $0.94 $2.23
Average True Range (ATR) 0.10 0.13
MACD -0.02 0.01
Stochastic Oscillator 26.85 55.56

Price Performance

Historical Comparison
TELA
DARE

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Share on Social Networks: